{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-022727","form_type":"8-K","ticker":"DYAI","cik":"0001213809","company_name":"DYADIC INTERNATIONAL INC","filed_at":"2026-05-13T20:11:27+00:00","discovered_at":"2026-05-13T20:13:00.301771+00:00","generated_at":"2026-05-13T22:03:32.331688+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Dyadic Q1 2026 revenue up 182% to $1.11M; net loss narrows to $(0.05)/share","bullets":["Q1 revenue $1,110,956 vs $393,572 YoY; net loss $(0.05)/share vs $(0.07) prior year.","Cash and investments $6.6M as of March 31, 2026, down from $8.6M at Dec 31, 2025.","Received initial purchase orders for recombinant bovine transferrin from cultivated meat customers.","Proliant Health launched AlbuFree™ DX, with Dyadic entitled to profit share; expanded Fermbox Bio collaboration.","Signed OEM distribution agreement with IBT Bioservices; advanced Gates Foundation RSV/malaria and CEPI/FBS H5 programs."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-022727","json":"https://secwatch.observer/filing/0001493152-26-022727.json","markdown":"https://secwatch.observer/filing/0001493152-26-022727.md","text":"https://secwatch.observer/filing/0001493152-26-022727.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1213809/000149315226022727/0001493152-26-022727-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1213809/000149315226022727/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-13T22:03:32.331688+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1b9e5846c00ae5caa0ac5ef163d6a2956427cfaa","claim":"DYADIC INTERNATIONAL INC reported financial results for Q1 2026.","evidence_excerpt":"Dyadic International, Inc. (“Dyadic”) issued a press release announcing its results for the quarter ended March 31, 2026.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1213809/000149315226022727/0001493152-26-022727-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Q1 2026"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}